Chinese firms had enjoyed a privileged position because of the country’s regulatory system. Photo: Alamy
Chinese firms had enjoyed a privileged position because of the country’s regulatory system. Photo: Alamy
China /  People & Culture

Pharma firms face shake-up with China’s plan to bulk-buy drugs

  • Pilot programme involves major cities clubbing together to purchase certain medicines, driving down prices
  • Chinese companies that have invested heavily in R&D stand best chance of survival

Topic |   Health in China
Bloomberg
Bloomberg

Updated: 4:41pm, 2 Jan, 2019

Why you can trust SCMP
Chinese firms had enjoyed a privileged position because of the country’s regulatory system. Photo: Alamy
Chinese firms had enjoyed a privileged position because of the country’s regulatory system. Photo: Alamy
READ FULL ARTICLE